Novelion Therapeutics Inc. (NVLN) declined -5.02% or -0.17 to $3.22. It is near to 16226 shares traded, which is 27.74% compare to the average total volume 58483. The market cap of NVLN is $59.76 million. The year to date change is -3.21%. The 52 week price range is from $3.08 to $8.26. Price of NVLN have changed -8.63% during last week. It have changed -14.61% over last month, -22.95% over last 3 months, -27.25% over last 6 months and -63.23% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NVLN is 3.72. It is 15.53% above current price. The 200-day Moving Averages for NVLN is 4.09. It is 27.02% above current price. The 52-week High is 8.26. It is 156.52% from the current price. The 52-week Low is 3.08. It is -4.35% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of NVLN is 11.86 on 2018-07-13. Short % to float is 10.81%. There are some statistics of NVLN. It is has market cap $59.76 million. The share outstanding is 18.56 million. The average volume is 58483. The revenue is 28.67M. The gross profit is -836000. The percent of top 15 Institution holding is 64.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NVLN is -273.91%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NVLN is -31.92%.